Short description
OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.
Description
OncoImmune is a clinical-stage biopharmaceutical company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. It has completed a Phase II clinical trial of CD24Fc for the prophylactic treatment of acute Graft versus Host Disease for leukemia patients undergoing hematopoietic stem cell transplantation and is poised to launch a pivotal trial for the indication.
Oncolmmune was founded in 2000 and is based in Rockville, Maryland.
Last funding
No Way
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Rockville, Maryland, United States, North America
Founded on
January 1, 2000
Exited on
November 23, 2020
Non-profit?
No
Acquired?
No
Employees count
5001+
Revenue range
$7890 - 12340
Sign in for full access
Investors
No Way, No Way, Uh Ohhhh, Noaccessforu, No Way
Sign in for full access
Founders
Kun-Liang Guan, Ming You, Pan Zheng, Yang Liu